Vitaeris Announces Multiple Scientific Presentations Involving...
VANCOUVER, British Columbia, May 22, 2019 /PRNewswire-AsiaNet/ -- - Anti-Interleukin 6 Monoclonal Antibody for Antibody-Mediated Kidney Transplant Rejection - 8 Oral & Poster Presentations Vitaeris Inc. (Vitaeris) today announced that eight abstracts involving or related to clazakizumab, Vitaeris' propri...
Authors: LATEST ASIANET NEWS RELEASES